SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): June 21, 2012
Bioflamex Corporation
(Exact name of registrant as specified in its charter)
| Nevada | 000-53712 | Pending |
| (State or other jurisdiction of incorporation) | (Commission File Number) | (I.R.S. Employer Identification No.) |
| Christiansvej 28, 2920 Charlottenlund, Denmark | ____________________ |
| (Address of principal executive offices) | (Zip Code) |
Registrant’s telephone number, including area code: 646-233-1310
|
___________________________________________________ (Former name or former address, if changed since last report) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| [ ] | Written communications pursuant to Rule 425 under the Securities Act (17CFR 230.425) |
| [ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| [ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| [ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
SECTION 4 - MATTERS RELATED TO ACCOUNTANTS AND FINANCIAL STATEMENTS
Item 4.02 Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review.
On June 21, 2012, the board of directors of Bioflamex Corp. (the “Company”) determined, upon advice of management, that the Company’s financial statements and related disclosures included in the Company’s Annual Report on Form 10-K for the year ended February 28, 2011 and the Company’s Quarterly Reports on Form 10-Q for the periods ended May 31, 2011, August 31, 2011 and November 30, 2011 (the “Previously Issued Financial Statements”) should be restated because they contain errors as addressed in Financial Accounting Standards Board Accounting Standards Codification Topic 250, Accounting Changes and Error Corrections. Accordingly, the Previously Issued Financial Statements issued by the Company should not be relied upon. The Company intends to restate the Previously Issued Financial Statements to correct these errors by amending its Annual Report for the year ended February 28, 2011 and its Quarterly Reports for the three months ended May 31, 2011, six months ended August 31, 2011, and nine months ended November 30, 2011.
The errors in the Previously Issued Financial Statements relate to certain liabilities and the corresponding expenses incurred and material agreements executed by the Company throughout the fiscal years ended February 29, 2012 and February 28, 2011, that were not previously disclosed.
As of the date of this Current Report, management of the Company has not had sufficient time to determine the impact of these errors on its financial condition, results of operations or cash flows reported in prior periods. Accordingly, the financial condition and results of operations disclosed in prior periods can no longer be relied upon.
FOR THE EFFECT OF THE RESTATEMENT OF THE FINANCIAL STATEMENTS OF THE COMPANY FOR THE YEAR ENDED FEBRUARY 28, 2011, PLEASE REFER TO THE AMENDMENTS TO OUR FORM 10-K FOR THE YEAR ENDED FEBRUARY 28, 2011 AND FORM 10-Q FOR THE PERIODS ENDED MAY 31, 2011, AUGUST 31, 2011 AND NOVEMBER 30, 2011, EXPECTED TO BE FILED BY JULY 20, 2012 OR A DATE SOON THEREAFTER.
The Company’s Board of Directors and management discussed the matters mentioned herein with Weaver, Martin & Samyn, LLC, the Company’s independent registered public accounting firm.
| 2 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
Bioflamex Corp.
/s/ Kristian Schiorring
Kristian Schiorring
Chief Executive Officer
Date: June 21, 2012
| 3 |